Screen · Berkshire Criteria

Buffett Quality Screen

Buffett's "wonderful business" criteria, quantified into six dimensions: earnings record (20), ROE quality (25 — Fortune's double standard), low leverage (15), pricing power (15), business stability (15) and capital efficiency (10), for a 0–100 total. The entry gate is the first of Berkshire's acquisition criteria — at least $50M average pre-tax earnings over the last three fiscal years (banks and insurers excluded, as leverage is their business model; investment trusts and closed-end funds excluded, as they are portfolios rather than operating companies). Recomputed periodically from each company's last ten fiscal years; cross-listings merged by canonical ticker. Hover the score for the six-dimension breakdown; companies we cover link to their report. Filtered by score tier "Top 90+", market cap "Mid $2–10B", profit streak "≥5 yr": 23 match(clear filters).

# Ticker Mkt Cap Score 10Y ROE Profit Streak Net Debt/Eq Gross Margin Report FY
1 AJ Bell plc AJB · LSE $2.9B
97/100 Elite
35.9%low 24.8% 10 yr+ Net cash 100% FY2025
2 Federated Investors Inc B FHI · US $4.6B
96/100 Elite
28.6%low 22.9% 10 yr+ Net cash 68% FY2025
3 Paycom Software, Inc. PAYC · US $7.6B
95/100 Elite
28.8%low 21.9% 10 yr+ Net cash 84% FY2025
4 WD-40 Company WDFC · US $3.0B
95/100 Elite
36.0%low 30.2% 10 yr+ 0.1× 54% FY2025
5 National Beverage Corp FIZZ · US $3.0B
95/100 Elite
41.0%low 28.7% 10 yr+ Net cash 37% FY2026
6 Games Workshop Group PLC GAW · LSE $8.0B
94/100 Elite
57.4%low 48.6% 10 yr+ Net cash 70% Games Workshop: An Exceptional Warhammer Compounder, Priced for Continued ExcellenceJun 26, 2026 · Hold FY2026
7 Rightmove PLC RMV · LSE $4.4B
94/100 Elite
60.0%low 60.0% 10 yr+ Net cash 100% FY2025
8 Exponent Inc EXPO · US $3.2B
94/100 Elite
26.7%low 22.8% 10 yr+ Net cash 60% FY2025
9 Nemetschek AG O.N. NEM · XETRA $7.2B
93/100 Elite
26.3%low 19.4% 10 yr+ 0.2× 53% FY2025
10 MarketAxess Holdings Inc MKTX · US $5.7B
93/100 Elite
25.1%low 19.7% 10 yr+ Net cash 77% FY2025
11 Shenzhen New Industries Biomedical 300832 · Shenzhen $5.3B
93/100 Elite
23.5%low 17.4% 10 yr+ Net cash 75% FY2025
12 Proya Cosmetics Co Ltd Class A 603605 · Shanghai $3.3B
93/100 Elite
22.1%low 13.8% 10 yr+ Net cash 66% FY2025
13 FactSet Research Systems Inc FDS · US $9.4B
92/100 Elite
40.4%low 27.3% 10 yr+ 0.6× 53% FactSet Research Systems Deep Value Investment ResearchMay 31, 2026 · Cautious Buy FY2025
14 Genpact Limited G · US $5.1B
92/100 Elite
20.4%low 16.8% 10 yr+ 0.2× 36% FY2025
15 Zhejiang Weixing New Building Materials Co Ltd 002372 · Shenzhen $2.0B
92/100 Elite
23.9%low 15.2% 10 yr+ Net cash 43% FY2025
16 Smith AO Corporation AOS · US $8.2B
91/100 Elite
23.4%low 13.5% 10 yr+ Net cash 39% A. O. Smith Water Heaters & Water Treatment Deep DiveMay 23, 2026 · Watch FY2025
17 Jiangsu King's Luck Brewery Joint-Stock Co Ltd 603369 · Shanghai $5.0B
91/100 Elite
19.7%low 15.7% 10 yr+ Net cash 74% FY2025
18 Hubei Jumpcan Pharmaceutical Co Ltd 600566 · Shanghai $3.4B
91/100 Elite
21.6%low 12.2% 10 yr+ Net cash 83% FY2025
19 IMI PLC IMI · LSE $8.8B
90/100 Elite
24.4%low 21.3% 10 yr+ 0.5× 45% FY2025
20 Chemed Corp CHE · US $7.1B
90/100 Elite
29.2%low 18.2% 10 yr+ 0.1× 33% FY2025
21 Howden Joinery Group Plc HWDN · LSE $5.5B
90/100 Elite
32.1%low 20.5% 10 yr+ 0.3× 62% FY2025
22 Ninety One PLC N91 · LSE $2.7B
90/100 Elite
51.3%low 21.9% 10 yr+ Net cash 64% FY2026
23 Hangzhou Robam Appliances Co Ltd 002508 · Shenzhen $2.1B
90/100 Elite
19.8%low 10.9% 10 yr+ Net cash 53% FY2025

Data and methodology: the six dimensions quantify Berkshire's published acquisition criteria and Buffett's shareholder letters (1981/1987/1991/2007 among others). Qualitative tests in the originals (e.g. "simple, understandable business", "management in place") are out of scope, and price ("available at a fair price") is covered by each report's valuation range instead. Financials come from company annual reports (via EODHD); ratios are computed in reporting currency, the USD gate via static FX. "‡" marks companies whose equity is persistently negative or tiny (ROE falls back to ROCE); "†" marks missing gross profit (operating margin used). Investment trusts and closed-end funds are excluded on two tests — name and financial shape (operating margins beyond what an operating company can achieve); REITs and operating asset managers are unaffected. This is a quantitative first pass, not investment advice. When citing this data, please credit Zen Horizon (zh.app). See our methodology for the scoring process.